Need to be careful with the analysis given SPA is still essentially a retail business and everyone knows Q2 is the big one each year. For ARR performance Q2FY25 will be an important test. I accept that inventory build up is critical in Q1FY25 to deliver a strong Q2. SPA is diversifying revenue streams domestically and internationally without burning too much cash but it is still a retail business model. A lot to unpack in the 4C. DYOR.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.96M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 15.0¢ | $4.828K | 31.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15569 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 25699 | 3 |
View Market Depth
| Last trade - 14.06pm 28/07/2025 (20 minute delay) ? |
| SPA (ASX) Chart |